Skip to content
Medical Health Aged Care

*** MEDIA ALERT *** Congratulating Queensland’s RACGP Award winners

Royal Australian College of GPs < 1 mins read

The Royal Australian College of General Practitioners (RACGP) is congratulating this year’s outstanding Queensland RACGP Award winners.

The winners are:

  • Dr Kuinileti Chang Wai working in Beenleigh has won GP of the Year.
  • Dr Craig Morris from the northern Brisbane suburbs has won GP Supervisor of the Year.
  • Dr Morgan Etienne from the Hope Island Medical Centre has won GP in Training of the Year.
  • Family Doctors Plus Windsor including Dr Maria Boulton has won General Practice of the Year.

All award winners are available for interview.

~ENDS


About us:

About the RACGP

The Royal Australian College of General Practitioners (RACGP) was established in 1958 and is Australia’s peak general practice representative organisation.

The RACGP has more than 41,000 members working in or towards a career in general practice, more than 9,500 of them live and work in rural and remote areas of the country. Nine in every 10 GPs are with the RACGP.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser
[email protected] (we will respond promptly to all requests for interview)

Stuart Winthrope
Media Adviser
[email protected]

 

Follow us on Twitter: @RACGP and Facebook.

More from this category

  • Medical Health Aged Care
  • 07/12/2025
  • 01:41
Takeda Pharmaceutical Company Limited

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline NEWARK,…

  • Medical Health Aged Care
  • 06/12/2025
  • 02:11
Arthur D. Little

Arthur D. Little and Vega IT Unveil Joint Venture for Digital Innovation

NEW YORK–BUSINESS WIRE– Arthur D. Little (ADL) and Vega IT today announced the formation of Axceler8 Solutions, a 50/50 joint venture created to design,…

  • Contains:
  • Medical Health Aged Care, Women
  • 05/12/2025
  • 10:11
Breast Cancer Trials

Bec’s Christmas wish amid cancer treatment

This Christmas, Bec’s wish is for her daughters to never face a breast cancer diagnosis like she has. “The only thing tougher than telling…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.